EIGHTEENTH Annual Meeting: Transatlantic Heart Failure Biomarker Working Group

Classical and Novel Biomarkers and Omics in CVD – Driving Toward More Medical Value

Role of Biomarkers and Omics In Promoting Progress in CV Science and CV CarePrecision Medicine

Doctor Kirkwood F. Adams, Jr (Chapel Hill, United States), along with Professor Faiez Zannad (Nancy, France) have the pleasure of inviting you to the 20th anniversary edition of the Transatlantic Heart Failure Biomarker Working Group Annual Meeting, taking place in Hôtel Barrière Le Gray d'Albion, in Cannes, France on April 26 and 27, 2025.

The Biomarkers meeting features a unique format that integrates academic, clinical, and industry leaders in a work group environment. This forum allows interchange on the application of biomarkers, genotyping, Omics and proteomics in the clinical care and research of patients with heart failure.

It is our pleasure to advise that the meeting has been assessed and found to be COMPLIANT with the MedTech Europe Code of Ethical Business Practice. To view the assessment decision, please click here

We are looking forward to welcoming you in the French Riviera in the spring of 2025.

With our best regards,

Workshop Co-Chairmen

Dr Kirkwood F. Adams, Jr (Chapel Hill, US) & Prof Faiez Zannad (Nancy, FR)